Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Head & Neck 3Breast 2Thoracic 1Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hyperplasia × Breast × Clear all
NCT02121873 2023-07-20

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Atossa Therapeutics, Inc.

Completed
6 enrolled
BreastOther neoplasm

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hyperplasia, Precancerous Conditions

NCT00339248 2009-03-13

Markers for Breast Cancer

National Institutes of Health Clinical Center (CC)

Completed
2,632 enrolled
Breast

Breast Neoplasms, Hyperplasia, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡